Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117083) titled 'Impact of Pharmacological Intervention on Clinical Outcomes in Borderline High-Altitude Pulmonary Hypertension: A Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial' on Jan. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Affiliated Hospital of the Army Medical University
Condition:
High-altitude pulmonary hypertension
Intervention:
Intervention Group:Receive Ambrisentan Treatment
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-21
Target Sample Size: Intervention Group:356;Control Group:356;
Countries of R...